semaglutide no longer compounded On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is considered in shortage, signaling an improvement in national supply. As a result, compounding Addressing the Weight Loss Injectable

The bowel-stimulating effect of coffee works even with decaffeinated varieties, though regular coffee tends to produce stronger results

Most cases were mild to moderate side effects and tended to decrease gradually with prolonged treatment," Jiang explained

In that study, 68.4% of the VAX-D group achieved at least a 50% pain reduction, while none of the patients in the TENS group did (Naguszewski et al., 2001)

Current Evidence The straightforward answer is that whilst preliminary research is encouraging, there is currently no official link established between GLP-1 receptor agonist use and dementia prevention or treatment